POST-PRESENTATION SURVEY
Q1
I am a(n)...
MD/DO
NP
PA
RN
PharmD
Other
MD/DO
NP
PA
RN
PharmD
Other
Q2
How many years have you been in practice?
1-5
6-10
11-15
16-20
Over 20
1-5
6-10
11-15
16-20
Over 20
Q3
Please describe your practice setting:
Solo Practice
Group Practice
Hospital Setting
Clinic
Other
Solo Practice
Group Practice
Hospital Setting
Clinic
Other
Q4
Number of patients seen per month with T2DM
1-10
11-20
21-30
31-40
41-50
Over 50
1-10
11-20
21-30
31-40
41-50
Over 50
Q5
Please rate the following:
Unsatisfactory
Needs Improvement
Average
Above Average
Excellent
Degree to which educational expectations met
Degree to which educational expectations met Unsatisfactory
Degree to which educational expectations met Needs Improvement
Degree to which educational expectations met Average
Degree to which educational expectations met Above Average
Degree to which educational expectations met Excellent
Material was relevant to my practice
Material was relevant to my practice Unsatisfactory
Material was relevant to my practice Needs Improvement
Material was relevant to my practice Average
Material was relevant to my practice Above Average
Material was relevant to my practice Excellent
Effective Faculty Presenter
Effective Faculty Presenter Unsatisfactory
Effective Faculty Presenter Needs Improvement
Effective Faculty Presenter Average
Effective Faculty Presenter Above Average
Effective Faculty Presenter Excellent
Overall Program
Overall Program Unsatisfactory
Overall Program Needs Improvement
Overall Program Average
Overall Program Above Average
Overall Program Excellent
Q6
As a result of what you have learned during this program, will you change your practice behaviors?
No
Unlikely
Unsure
Probably
Absolutely
No
Unlikely
Unsure
Probably
Absolutely
Q7
What will you change? Choose all that apply
Prescribe more GLP-1 receptor agonists
Review my patients' medications
More closely consider guidelines in my treatment
Will be more aware of cardiovascular disease as a danger to my patients with diabetes
Will learn more about newer diabetes treatments
Will share what I have learned with my staff and colleagues
Will better educate my patients about their treatment options
Other
Q8
Please describe what you will change if you selected "Other."
Q9
What barriers to change do you foresee, if any? Select all that apply.
Cost
Insurance Coverage
Formulary
Time with Patient
Patient compliance
Other
Cost
Insurance Coverage
Formulary
Time with Patient
Patient compliance
Other
Q10
If you selected "Other," please describe the barrier(s) you foresee.
Q11
Did the content contribute valuable information that will assist in improving patient outcomes?
Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
Q12
Please rate your ability to achieve the Learning Objectives of this presentation:
Not at all
Somewhat
Mostly
Completely
Not at all
Somewhat
Mostly
Completely
Q13
What was your level of expertise on this topic?
None
Little
Some
Considerable
Extensive
BEFORE
BEFORE
None
BEFORE
Little
BEFORE
Some
BEFORE
Considerable
BEFORE
Extensive
AFTER
AFTER
None
AFTER
Little
AFTER
Some
AFTER
Considerable
AFTER
Extensive
Q14
Do you believe the activity was fair and balanced, free from commercial influences?
Yes
No
Yes
No
Q15
Did the program increase your competence?
Yes
No
Yes
No
Q16
What does MACE stand for in terms of the outcomes of the cardiovascular outcomes trials?
Minor Adverse Cardiovascular Events
Major Adverse Cardiovascular Events
Multiple Additional Cardiovascular Event
Major Additional Cardiovascular Events
Q17
Which GLP1-RAs have been approved by the FDA for reduction of cardiovascular risk?
Dulaglutide
Liraglutide
Semaglutide
All of the above
Q18
How confident are you in your answer to the last question?
Not at all
Somewhat
Confident
Very confident
Not at all
Somewhat
Confident
Very confident
Q19
Click submit to move to printing your certificate and add any additional comments you may have below. Thank you!